文献速递骨肌USDR

影像引导下跟骨后滑囊皮质类固醇注射治疗跟骨后滑囊炎的安全性与疗效

Safety and efficacy of image-guided retrocalcaneal bursa corticosteroid injection for the treatment of retrocalcaneal bursitis.
PubMed 文献 · Skeletal Radiol · 2021-05-21

回顾性评估2013-2019年218例影像引导下跟骨后滑囊皮质类固醇注射,短期随访62例中62.9%获优良缓解(p<0.00001),14%后续行跟腱手术,跟腱断裂率1.8%,滑囊多普勒血流与进展至手术相关(p=0.00042)。

要点

  • 滑囊多普勒血流与进展至手术显著相关(p=0.00042),可能为负性预后指标。
  • 短期随访62例中62.9%获优良疼痛缓解(p<0.00001)。
  • 跟腱断裂率1.8%(4例),均发生于注射后15-59天且前有急性损伤。

核心结论

  • 影像引导下跟骨后滑囊皮质类固醇注射使多数(63%)患者短期疼痛评分显著下降,后续跟腱断裂率为1.8%,滑囊多普勒血流与进展至手术显著相关并可能为负性预后指标。

研究设计与样本

  • 经IRB批准后回顾性评估2013-2019年所有透视引导和超声引导下跟骨后滑囊注射,共218例注射(181例女性,平均54.5岁),超声引导157例(72%)、透视引导61例(28%)。

关键影像表现/征象

  • 术前超声和X线由2名盲法放射科医生共识评分:跟腱变性及跟骨后滑囊炎采用0-3分评分,跟腱附着点病变和Haglund畸形采用有/无记录。
  • 滑囊多普勒血流与进展至手术显著相关(p=0.00042)。

诊断标准与关键数值

  • 短期疗效按疼痛评分(0-10分)较术前下降幅度分级:优(下降7-10分)、良(下降4-6分)、可(下降1-3分)或无反应。
  • 短期随访62例中优良应答率为62.9%(p<0.00001)。

临床应用与阅片要点

  • 术前超声评估滑囊多普勒血流可能有助于识别进展至手术风险较高的患者。
  • 超声引导与透视引导两组 outcomes 无差异。
  • 注射后15-59天出现的跟腱断裂均有前驱急性损伤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine the safety and efficacy of image-guided retrocalcaneal bursa corticosteroid injection for retrocalcaneal bursitis.

MATERIALS AND METHODS: After IRB approval, all fluoroscopically guided and ultrasound-guided retrocalcaneal bursa injections (2013-2019) were retrospectively evaluated. Pre-procedure US and radiographs were scored by 2 blinded radiologists in consensus for Achilles tendinosis and retrocalcaneal bursitis (0-3 scale), Achilles enthesopathy (present/absent), and Haglund deformity (present/absent). Pre- and post-procedure pain scores (0-10 scale) evaluated short-term response at 1-4 weeks: excellent (7-10 point decline), good (4-6 point decline), fair (1-3 point decline), or no response. Paired t-test determined significance of short-term improvement. Kaplan-Meier method analyzed time to progression to surgery or complication at 6-month minimum follow-up. Logistic regression analysis evaluated for association between demographic and imaging variables and negative outcome.

RESULTS: Two hundred eighteen injections (181 female; mean 54.5 years) performed under ultrasonographic (157, 72%) or fluoroscopic (61, 28%) guidance were evaluated for complication and long-term outcomes. Injections with short-term follow-up (n = 62) yielded excellent or good response in 62.9% (p < 0.00001). Thirty patients (14%) had subsequent elective Achilles surgery. Bursal Doppler flow was associated with progression to surgery (p = 0.00042). No differences were identified in outcomes between US and fluoroscopic-guidance cohorts. Four Achilles ruptures (1.8%) were identified 15-59 days post-injection, each with immediately preceding acute injury.

CONCLUSION: Image-guided retrocalcaneal bursa corticosteroid injection yields significant short-term decrease in pain score in majority (63%) of patients. Subsequent Achilles tendon rupture rate was 1.8%. Bursa Doppler flow was significantly correlated with progression to surgery and may represent a negative prognostic indicator.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Boone SL, Uzor R, Walter E, et al. Safety and efficacy of image-guided retrocalcaneal bursa corticosteroid injection for the treatment of retrocalcaneal bursitis. Skeletal Radiol. 2021. PMID: 34019132. doi:10.1007/s00256-021-03783-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。